Corvus Pharmaceuticals, Inc. (CRVS): EPS (Diluted)
-$0.53
Year ended 2025-12-31
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$0.53 | n/m | 2026-03-12, From 2025-01-01 |
| 2024-12-31 | -$1.02 | n/m | 2026-03-12, From 2024-01-01 |
| 2023-12-31 | -$0.56 | n/m | 2026-03-12, From 2023-01-01 |
| 2022-12-31 | -$0.89 | n/m | 2025-03-25, From 2022-01-01 |
| 2021-12-31 | -$1.03 | n/m | 2024-03-19, From 2021-01-01 |
| 2020-12-31 | -$0.20 | n/m | 2023-03-28, From 2020-01-01 |
| 2019-12-31 | -$1.59 | n/a | 2022-03-10, From 2019-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Corvus Pharmaceuticals, Inc. (CRVS) | 2025-12-31 | -$0.53 | n/m |
| Aldeyra Therapeutics, Inc. (ALDX) | 2025-12-31 | -$0.56 | n/m |
| Werewolf Therapeutics, Inc. (HOWL) | 2025-12-31 | -$1.33 | n/m |
| Spero Therapeutics, Inc. (SPRO) | 2025-12-31 | $0.15 | n/m |
| Context Therapeutics Inc. (CNTX) | 2025-12-31 | -$0.38 | n/m |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | -$1.81 | n/m |
| Grace Therapeutics, Inc. (GRCE) | 2026-03-31 | -$0.47 | n/m |
| Cumberland Pharmaceuticals Inc (CPIX) | 2025-12-31 | -$0.19 | n/m |
| Adagene Inc. (ADAG) | 2025-12-31 | -$0.30 | n/m |
Compare CRVS, ALDX, HOWL, SPRO side by side · Screen every company in Pharmaceutical Preparations ↗